SciClaims: An End-to-End Generative System for Biomedical Claim Analysis

• URL: http://arxiv.org/abs/2503.18526v1
• Date: Mon, 24 Mar 2025 10:31:31 GMT
• Title: SciClaims: An End-to-End Generative System for Biomedical Claim Analysis
• Authors: Raúl Ortega, José Manuel Gómez-Pérez,
• Abstract summary: SciClaims is an advanced system powered by state-of-the-art large language models (LLMs)<n>It seamlessly integrates the entire scientific claim analysis process.<n>SciClaims outperforms previous approaches in both claim extraction and verification without requiring additional fine-tuning.
• Score: 0.138120109831448
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Validating key claims in scientific literature, particularly in biomedical research, is essential for ensuring accuracy and advancing knowledge. This process is critical in sectors like the pharmaceutical industry, where rapid scientific progress requires automation and deep domain expertise. However, current solutions have significant limitations. They lack end-to-end pipelines encompassing all claim extraction, evidence retrieval, and verification steps; rely on complex NLP and information retrieval pipelines prone to multiple failure points; and often fail to provide clear, user-friendly justifications for claim verification outcomes. To address these challenges, we introduce SciClaims, an advanced system powered by state-of-the-art large language models (LLMs) that seamlessly integrates the entire scientific claim analysis process. SciClaims outperforms previous approaches in both claim extraction and verification without requiring additional fine-tuning, setting a new benchmark for automated scientific claim analysis.

Related papers

• LLM Agent Swarm for Hypothesis-Driven Drug Discovery [2.7036595757881323]
  PharmaSwarm is a unified multi-agent framework that orchestrates specialized "agents" to propose, validate, and refine hypotheses for novel drug targets and lead compounds. By acting as an AI copilot, PharmaSwarm can accelerate translational research and deliver high-confidence hypotheses more efficiently than traditional pipelines.
  arXiv  Detail & Related papers  (2025-04-24T22:27:50Z)
• Systematic Literature Review on Clinical Trial Eligibility Matching [0.24554686192257422]
  Review highlights how explainable AI and standardized ontology can bolster clinician trust and broaden adoption.<n>Further research into advanced semantic and temporal representations, expanded data integration, and rigorous prospective evaluations is necessary to fully realize the transformative potential of NLP in clinical trial recruitment.
  arXiv  Detail & Related papers  (2025-03-02T11:45:50Z)
• RAG-Enhanced Collaborative LLM Agents for Drug Discovery [28.025359322895905]
  CLADD is a retrieval-augmented generation (RAG)-empowered agentic system tailored to drug discovery tasks.<n>We show that it outperforms general-purpose and domain-specific LLMs as well as traditional deep learning approaches.
  arXiv  Detail & Related papers  (2025-02-22T00:12:52Z)
• Iterative Tree Analysis for Medical Critics [5.617649111108429]
  Iterative Tree Analysis (ITA) is designed to extract implicit claims from long medical texts and verify each claim through an iterative and adaptive tree-like reasoning process.<n>Our experiments demonstrate that ITA significantly outperforms previous methods in detecting factual inaccuracies in complex medical text verification tasks by 10%.
  arXiv  Detail & Related papers  (2025-01-18T03:13:26Z)
• Towards Reliable Medical Question Answering: Techniques and Challenges in Mitigating Hallucinations in Language Models [1.03590082373586]
  This paper conducts a scoping study of existing techniques for mitigating hallucinations in knowledge-based task in general and especially for medical domains. Key methods covered in the paper include Retrieval-Augmented Generation (RAG)-based techniques, iterative feedback loops, supervised fine-tuning, and prompt engineering. These techniques, while promising in general contexts, require further adaptation and optimization for the medical domain due to its unique demands for up-to-date, specialized knowledge and strict adherence to medical guidelines.
  arXiv  Detail & Related papers  (2024-08-25T11:09:15Z)
• Chemist-X: Large Language Model-empowered Agent for Reaction Condition Recommendation in Chemical Synthesis [57.70772230913099]
  Chemist-X automates the reaction condition recommendation (RCR) task in chemical synthesis with retrieval-augmented generation (RAG) technology. Chemist-X interrogates online molecular databases and distills critical data from the latest literature database. Chemist-X considerably reduces chemists' workload and allows them to focus on more fundamental and creative problems.
  arXiv  Detail & Related papers  (2023-11-16T01:21:33Z)
• Self-Verification Improves Few-Shot Clinical Information Extraction [73.6905567014859]
  Large language models (LLMs) have shown the potential to accelerate clinical curation via few-shot in-context learning. They still struggle with issues regarding accuracy and interpretability, especially in mission-critical domains such as health. Here, we explore a general mitigation framework using self-verification, which leverages the LLM to provide provenance for its own extraction and check its own outputs.
  arXiv  Detail & Related papers  (2023-05-30T22:05:11Z)
• ChemVise: Maximizing Out-of-Distribution Chemical Detection with the Novel Application of Zero-Shot Learning [60.02503434201552]
  This research proposes learning approximations of complex exposures from training sets of simple ones. We demonstrate this approach to synthetic sensor responses surprisingly improves the detection of out-of-distribution obscured chemical analytes.
  arXiv  Detail & Related papers  (2023-02-09T20:19:57Z)
• SciFact-Open: Towards open-domain scientific claim verification [61.288725621156864]
  We present SciFact-Open, a new test collection designed to evaluate the performance of scientific claim verification systems. We collect evidence for scientific claims by pooling and annotating the top predictions of four state-of-the-art scientific claim verification models. We find that systems developed on smaller corpora struggle to generalize to SciFact-Open, exhibiting performance drops of at least 15 F1.
  arXiv  Detail & Related papers  (2022-10-25T05:45:00Z)
• Generating Scientific Claims for Zero-Shot Scientific Fact Checking [54.62086027306609]
  Automated scientific fact checking is difficult due to the complexity of scientific language and a lack of significant amounts of training data. We propose scientific claim generation, the task of generating one or more atomic and verifiable claims from scientific sentences. We also demonstrate its usefulness in zero-shot fact checking for biomedical claims.
  arXiv  Detail & Related papers  (2022-03-24T11:29:20Z)
• Scientific Claim Verification with VERT5ERINI [57.103189505636614]
  This work describes the adaptation of a pretrained sequence-to-sequence model to the task of scientific claim verification in the biomedical domain. We propose VERT5ERINI that exploits T5 for abstract retrieval, sentence selection and label prediction. We evaluate our pipeline on SCIFACT, a newly curated dataset that requires models to not just predict the veracity of claims but also provide relevant sentences from a corpus of scientific literature that support this decision.
  arXiv  Detail & Related papers  (2020-10-22T17:56:33Z)
• Machine Learning in Nano-Scale Biomedical Engineering [77.75587007080894]
  We review the existing research regarding the use of machine learning in nano-scale biomedical engineering. The main challenges that can be formulated as ML problems are classified into the three main categories. For each of the presented methodologies, special emphasis is given to its principles, applications, and limitations.
  arXiv  Detail & Related papers  (2020-08-05T15:45:54Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.